中性粒细胞特征与痛风患者心血管风险增加密切相关
该研究纳入阿姆斯特丹Reade痛风队列的75例连续痛风患者,分析血浆中性粒细胞胞外诱捕网(NETs)及中性粒细胞活化标志物(钙卫蛋白和过氧化物酶活性),并与健康对照比较。结果显示痛风患者NETs水平升高但与心血管风险无关,而过氧化物酶活性与腰臀比、胆固醇比值、甘油三酯及10年心血管死亡风险相关;同时具有高过氧化物酶和钙卫蛋白水平的中性粒细胞活化特征与心血管风险评分显著升高相关。
要点
- 痛风患者NETs水平升高,但与心血管风险无关。
- 过氧化物酶活性与腰臀比、胆固醇比值、甘油三酯及10年心血管死亡风险相关。
- 高过氧化物酶和钙卫蛋白的中性粒细胞活化特征与心血管风险评分显著升高相关。
核心结论
- 痛风患者中性粒细胞活化标志物MPO和钙卫蛋白水平较健康对照升高。
- 中性粒细胞活化标志物与高脂血症、高血压和糖尿病等心血管疾病危险因素相关。
- 中性粒细胞活化特征的存在与10年心血管死亡风险增加强烈相关。
研究设计与样本
- 研究收集了参与阿姆斯特丹Reade痛风队列的75例连续痛风患者的数据。
- 通过ELISA和荧光法分析血浆中NETs水平及中性粒细胞活化标志物(钙卫蛋白和过氧化物酶活性),并与健康对照比较。
主要发现
- 痛风患者NETs水平升高,但升高水平与心血管风险无关。
- 过氧化物酶活性与腰臀比(β=0.33,P<0.001)、胆固醇比值(β=0.46,P<0.005)、甘油三酯(β=0.60,P<0.001)及10年心血管死亡风险(β=0.44,P=0.001)相关。
- 钙卫蛋白水平在高血压(P=0.005)和糖尿病(P=0.02)中升高。
- 同时具有高过氧化物酶和钙卫蛋白水平的中性粒细胞活化特征的患者心血管风险评分显著升高(P=0.001),68%的患者具有高心血管风险(比值比2.9,P=0.03)。
关键数值与推荐
- 过氧化物酶活性与腰臀比的β=0.33,P<0.001。
- 过氧化物酶活性与胆固醇比值的β=0.46,P<0.005。
- 过氧化物酶活性与甘油三酯的β=0.60,P<0.001。
- 过氧化物酶活性与10年心血管死亡风险的β=0.44,P=0.001。
- 高心血管风险比值比2.9,P=0.03,68%的患者具有高心血管风险。
临床怎么用
- 在痛风患者中可关注中性粒细胞活化标志物(过氧化物酶和钙卫蛋白)以评估心血管风险。
- 中性粒细胞活化特征可能有助于识别心血管风险较高的痛风患者。
局限性
- 需要进一步研究确定痛风特异性因素和/或心血管危险因素是否 contribute 于这些患者中观察到的中性粒细胞活化升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between neutrophil activation and cardiovascular risk in gout patients. We hypothesize that neutrophil activation mediates inflammation and therefore takes part in atherogenesis in gout patients. METHOD: Patient data were collected from 75 consecutive gout patients participating in the Reade gout cohort Amsterdam. Levels of neutrophil extracellular traps (NETs) and neutrophil activation (calprotectin and peroxidase activity) were analysed by ELISA and fluorimetry in plasma and compared with healthy controls. Markers of neutrophil activation were related to clinical markers of cardiovascular risk, including BMI, smoking, blood pressure, lipid profile and 10 year risk of cardiovascular mortality (EU-SCORE). RESULTS: Increased levels of NETs were found in gout patients, although increased levels were not associated with cardiovascular risk. However, markers of neutrophil activation, including peroxidase activity correlated with waist:hip ratio (β = 0.33, P < 0.001), cholesterol ratio (β = 0.46, P < 0.005) and triglycerides (β = 0.60, P < 0.001) as well as the 10 year risk of cardiovascular mortality (β = 0.44, P = 0.001). Calprotectin levels were elevated in hypertension (P = 0.005) and diabetes (P = 0.02). Finally, gout patients with high levels of both peroxidase and calprotectin ('neutrophil activation signature') had a markedly elevated cardiovascular risk score (P = 0.001), with 68% of the patients having high cardiovascular risk (odds ratio 2.9, P = 0.03). CONCLUSION: We demonstrated elevated levels of neutrophil activation markers, MPO and calprotectin in gout patients as compared with healthy controls. Of note, neutrophil activation markers were associated with several risk factors for cardiovascular disease, including hyperlipidaemia, hypertension and diabetes. Finally, the presence of a neutrophil activation signature was strongly associated with an increased 10 year risk of cardiovascular mortality. Further studies are needed to determine whether gout-specific factors and/or cardiovascular risk factors contribute to the elevated neutrophil activation observed in these patients.
引用
- Vedder D, Gerritsen M, Nurmohamed MT, et al. A neutrophil signature is strongly associated with increased cardiovascular risk in gout. Rheumatology (Oxford). 2021. PMID: 33188698. doi:10.1093/rheumatology/keaa712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。